Hong Kong's $40 Billion IPO Queue: Why the Comeback Is About Capital Supply, Not China Beta
Hong Kong's IPO rebound is real, but it is a capital-supply story before it is a China risk-on signal. The next test is post-listing discipline.
Hong Kong has gone from an IPO drought to a queue-management problem. More than 100 companies have listed in the city this year, raising more than $40 billion and already beating the $37 billion raised in all of 2025. The number is large enough to invite the easy conclusion that global investors have fallen back in love with China. The better reading is more specific: Hong Kong is rebuilding its capital-supply machine, and the next test is whether that supply can produce durable secondary-market returns.
The distinction matters. A China risk-on rally would normally be led by a broad improvement in earnings, currencies and offshore flows. The Hong Kong rebound is being led first by issuance, follow-on deals and the mechanics of connecting mainland companies with international capital. That makes the exchange a beneficiary of activity even when investors remain selective about China beta. In other words, this is a market-structure story before it is a macro story.
The queue is the signal
The scale of the pipeline is difficult to dismiss. Hong Kong Exchanges and Clearing's own listing data show 421 new Main Board applications accepted between Jan. 1 and July 31, with 102 Main Board companies and two GEM companies listed in the same period. At the end of July, 474 applications were still under processing on the Main Board, or 485 including GEM. That is not simply a backlog left over from a weak cycle. It is a live inventory of companies willing to spend time and money to access the venue.
Independent estimates point in the same direction. KPMG counted more than 500 active applicants, including confidential filings, in its mid-year review, with 443 publicly filed as of June 26. Of those, 116 were A+H candidates and 145 were technology companies. The technology component has attracted the headlines, but the more important market signal is the mix: advanced manufacturing, healthcare, consumer and industrial issuers are using the same platform.
Bonnie Chan, chief executive officer of Hong Kong Exchanges and Clearing, told CNBC's Emily Tan in an interview published Aug. 20 that “We still have a lot of pretty good high quality companies in the pipeline trying to get their IPOs done before the end of the year.” That is a statement about throughput, but it is also a warning about selection. A queue is valuable only if the exchange can preserve underwriting standards while moving the best applicants through the door.
The exchange is already monetizing the traffic. HKEX reported first-half net profit of HK$10.57 billion, up 24% from a year earlier, according to Reuters. Listing fees rose 36% to HK$590 million, while 87 listings raised HK$212 billion, up 94% year on year. Average daily turnover rose 18% to HK$283 billion. The operating leverage is clear: when primary issuance and secondary trading revive together, the exchange captures both sides of the reopening.
Official monthly data show the momentum continued into July. IPO proceeds reached HK$328.214 billion in the first seven months, up 153.9% from a year earlier, while total funds raised, including follow-on transactions, reached HK$527.988 billion, up 56.7%. July average daily turnover was HK$307.2 billion, 17% above the same month last year. The market capitalization of listed companies stood at HK$46.8 trillion at month-end.
Not all liquidity is the same
Those figures explain why this rebound should not be treated as a simple vote on China's economic cycle. Liquidity is arriving through several channels at once: mainland companies are pursuing A+H structures, existing issuers are raising follow-on capital, and international companies are testing Hong Kong as a complementary venue. The capital is not necessarily saying that every Chinese company deserves a higher multiple. It is saying that Hong Kong can still aggregate demand, price risk and distribute shares across a broader investor base.
Johnson Chui, head of global issuer services at HKEX, told Reuters in May that “We feel that this is the start of a structural change of the next phase of international companies listing in Hong Kong.” The evidence is still early. Reuters reported that about 10 international companies had filed or were exploring listings, including firms from Indonesia, South Korea and Singapore. But the direction is meaningful: the venue is trying to move beyond the old model in which an issuer needed obvious Greater China revenue to justify a Hong Kong listing.
That broadening is visible in the sectors Chan highlighted to CNBC. Biotechnology, mining and consumer companies are sitting alongside AI and other technology issuers in the pipeline. It is a healthier composition than a single-theme surge, but it does not eliminate valuation risk. A diversified queue can still produce a crowded market if the same investors are asked to absorb too many deals at once.
The first-day numbers are encouraging, though not conclusive. Eddie Wong, capital markets leader at PwC Hong Kong, wrote in the firm's July 2 mid-year review, “We expect Hong Kong's IPO fundraising to reach HK$380 billion this year, positioning Hong Kong firmly among the world's top three IPO markets.” PwC also said the proportion of first-day gainers rose from around 70% in the first half of 2025 to more than 80% in the first half of 2026.
But a good debut is not the same thing as a good public company. CNBC reported in June that about half of 179 Hong Kong listings since January 2025 had traded lower over the following three months. Several stocks that had surged more than 300% before entering the Stock Connect later fell at least 10%. The pattern is familiar: scarcity creates an exciting first print, then a larger float, lock-up expiries and quarterly disclosure force investors to decide whether the original price was justified.
That is why the next phase will be less about the headline fundraising total and more about aftermarket discipline. The exchange extended the listing application window from six months to 12 months for a limited period as it dealt with a pipeline of around 500 companies, according to the South China Morning Post. The reform reduces the risk that a strong issuer is forced to restart its application simply because the timetable is crowded. It also acknowledges that the market has a capacity constraint.
Shein will be an important case study. Bloomberg reported on Aug. 13 that the fast-fashion company was considering an Aug. 28 Hong Kong debut at a valuation of about $30 billion, a fraction of its peak, with investors pushing for a lower price. The deal is not a referendum on the whole exchange, but it will test whether a globally recognizable issuer can use Hong Kong's renewed liquidity without demanding the kind of growth multiple that the market is no longer willing to underwrite.
Bonnie Chan told Reuters, in remarks reported Aug. 19, “The market has regained its vibrancy and our focus now is on sustaining that momentum through discipline and execution.” The second half of that sentence is the part investors should keep. Vibrancy is visible in turnover and order books. Discipline will be visible in pricing, post-listing performance and the willingness of sponsors to let weak deals wait.
Our view is that Hong Kong's IPO recovery deserves to be treated as a structural reopening of Asian equity capital markets, not as a blanket signal to add China exposure. The winners are likely to be the exchange, high-quality issuers with genuine international funding needs and investors who can underwrite cash flows rather than chase first-day momentum. The risk is that the queue becomes the product: a large number of offerings creates the appearance of depth while quietly diluting the attention available to each new company.
The practical watchlist is therefore narrow. Track the conversion rate from the 474 applications under processing to completed listings, the share of proceeds coming from repeat A+H issuers, the performance of new stocks after their first lock-up expiry and the mix of international applicants. If those measures improve together, Hong Kong will be doing more than hosting a hot IPO season. It will be restoring its role as the region's capital allocator.
This note is for informational purposes only and does not constitute investment advice, an offer, or a solicitation to buy or sell any security.
Source notes: CNBC, Aug. 20, 2026; Reuters, Aug. 19, 2026; Reuters, May 20, 2026; PwC Hong Kong, July 2, 2026; HKEX Monthly Market Highlights; HKEX listing data; KPMG, June 30, 2026; Bloomberg, Aug. 13, 2026.
